Premium
Continuous Chlormadinone Acetate for Contraception: Preliminary Findings
Author(s) -
Leeton John
Publication year - 1969
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/j.1479-828x.1969.tb02542.x
Subject(s) - chlormadinone acetate , medicine , incidence (geometry) , breastfeeding , gynecology , population , obstetrics , research methodology , pediatrics , mathematics , geometry , environmental health
Summary1 Chlormadinone acetate, 0.5 mg. daily, has been assessed as a contraceptive drug. Drug and patient failure rates in this series were both 0.005/cycle of exposure. This was equivalent to a combined figure of 12 pregnancies 100 woman years. 2 Of 25 women who had previous sideeffects on at least 1 oral contraceptive, 15 had no symptoms on chlormadinone acetate. 3 Women taking chlormadinone acetate while breastfeeding showed no evidence of inhibition of lactation. 4 No significant difference in the incidence of side‐effects was found in a low economic group when compared with a private patient group.